TOLNAFTATE JOCK ITCH POWDER SPRAY TALC FREE

TOLNAFTATE JOCK ITCH POWDER SPRAY TALC FREE was reported 188 times

TOLNAFTATE JOCK ITCH POWDER SPRAY TALC FREE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MICRODONTIA 1 0.2500
1 URAEMIA ODOUR 1 0.1250
2 BRONCHITIS PNEUMOCOCCAL 1 0.0476
3 TOOTH HYPOPLASIA 8 0.0460
4 CHEST SCAN ABNORMAL 1 0.0303
5 ENAMEL ANOMALY 8 0.0280
6 SARCOMATOID MESOTHELIOMA 1 0.0133
7 ABDOMINAL WALL CYST 1 0.0082
8 BLADDER CYST 1 0.0062
9 SCHWANNOMA 1 0.0050
10 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 7 0.0050
11 MUCORMYCOSIS 11 0.0042
12 MORAXELLA INFECTION 1 0.0036
13 NERVE ROOT COMPRESSION 2 0.0035
14 ABDOMINAL WALL DISORDER 1 0.0034
15 MALOCCLUSION 1 0.0034
16 POSITIVE AIRWAY PRESSURE THERAPY 1 0.0034
17 HAEMATOLOGY TEST ABNORMAL 1 0.0031
18 CHRONIC RESPIRATORY DISEASE 1 0.0028
19 VAGINAL FISTULA 1 0.0028
20 CANCER PAIN 7 0.0027
21 LUNG CYST 1 0.0025
22 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 7 0.0025
23 PSEUDOMONAS TEST POSITIVE 2 0.0024
24 FUNGAL FOOT INFECTION 1 0.0023
25 CARBON DIOXIDE INCREASED 3 0.0022
26 GALLBLADDER RUPTURE 1 0.0022
27 TUBERCULOUS PLEURISY 1 0.0021
28 CHRONIC GRAFT VERSUS HOST DISEASE 7 0.0019
29 BLOOD IMMUNOGLOBULIN M INCREASED 1 0.0016
30 DRY GANGRENE 1 0.0016
31 MESOTHELIOMA 2 0.0015
32 BRONCHOPULMONARY ASPERGILLOSIS 11 0.0014
33 JUDGEMENT IMPAIRED 2 0.0014
34 HEAT EXHAUSTION 1 0.0012
35 SPUTUM CULTURE POSITIVE 1 0.0012
36 EXPOSURE TO CHEMICAL POLLUTION 2 0.0012
37 RELAPSING-REMITTING MULTIPLE SCLEROSIS 1 0.0012
38 RED BLOOD CELL COUNT INCREASED 3 0.0011
39 DENTAL CARE 2 0.0011
40 PHARYNGEAL HYPOAESTHESIA 1 0.0011
41 TELANGIECTASIA 1 0.0010
42 HYPERVIGILANCE 1 0.0010
43 REDUCED FACIAL EXPRESSION 1 0.0010
44 BLOOD CREATININE DECREASED 3 0.0010
45 STAPHYLOCOCCUS TEST POSITIVE 2 0.0009
46 PO2 DECREASED 1 0.0009
47 CHEMICAL BURN 1 0.0009
48 GROIN ABSCESS 1 0.0008
49 DEVICE DISPENSING ERROR 1 0.0008
50 GLUCOSE URINE PRESENT 1 0.0008
51 LIPOMA 2 0.0008
52 SINUS ARRHYTHMIA 1 0.0008
53 TUMOUR PAIN 1 0.0008
54 BLOOD POTASSIUM INCREASED 12 0.0007
55 RASH MORBILLIFORM 2 0.0007
56 CONTRAINDICATION TO MEDICAL TREATMENT 1 0.0007
57 URINE KETONE BODY PRESENT 1 0.0006
58 OEDEMA MOUTH 2 0.0006
59 METABOLIC SYNDROME 1 0.0006
60 ANTIBODY TEST POSITIVE 1 0.0006
61 CERVICAL SPINAL STENOSIS 1 0.0006
62 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 3 0.0006
63 PNEUMONIA KLEBSIELLA 1 0.0005
64 INJECTION SITE CELLULITIS 1 0.0005
65 TRAUMATIC LUNG INJURY 1 0.0005
66 LATENT TUBERCULOSIS 1 0.0005
67 ABSCESS LIMB 2 0.0005
68 TOOTH DISORDER 10 0.0004
69 HAEMATOCRIT INCREASED 1 0.0004
70 GRAFT VERSUS HOST DISEASE 3 0.0004
71 WRONG DOSE 1 0.0004
72 BREATH ODOUR 1 0.0004
73 HYPERVOLAEMIA 2 0.0004
74 INJECTION SITE ABSCESS 1 0.0004
75 SKIN LESION 11 0.0004
76 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 1 0.0004
77 TEMPOROMANDIBULAR JOINT SYNDROME 1 0.0004
78 CHOLECYSTITIS INFECTIVE 1 0.0004
79 LUMBAR SPINAL STENOSIS 1 0.0003
80 CREPITATIONS 1 0.0003
81 BRONCHIECTASIS 2 0.0003
82 DEPRESSION SUICIDAL 1 0.0003
83 TACHYPHRENIA 1 0.0003
84 WOUND 8 0.0003
85 CARPAL TUNNEL SYNDROME 4 0.0003
86 THERMAL BURN 2 0.0003
87 PRODUCT CONTAMINATION 1 0.0003
88 CAROTID ARTERY OCCLUSION 1 0.0003
89 RASH ERYTHEMATOUS 13 0.0003
90 TENDON INJURY 1 0.0003
91 MUCOSAL INFLAMMATION 7 0.0003
92 PROTEIN TOTAL DECREASED 1 0.0003
93 CARDIOPULMONARY FAILURE 1 0.0003
94 PNEUMONIA FUNGAL 1 0.0003
95 FUNGAL SKIN INFECTION 1 0.0002
96 BLOOD UREA INCREASED 4 0.0002
97 BUNDLE BRANCH BLOCK LEFT 1 0.0002
98 CARDIAC FAILURE CHRONIC 1 0.0002
99 ATRIOVENTRICULAR BLOCK FIRST DEGREE 1 0.0002
100 PHYSICAL DISABILITY 1 0.0002
101 BLOOD PRESSURE SYSTOLIC DECREASED 1 0.0002
102 NERVE COMPRESSION 2 0.0002
103 BLOOD CHOLESTEROL ABNORMAL 1 0.0002
104 SPUTUM DISCOLOURED 2 0.0002
105 GUILLAIN-BARRE SYNDROME 1 0.0002
106 KNEE OPERATION 2 0.0002
107 DIABETIC NEUROPATHY 1 0.0002
108 PATHOLOGICAL FRACTURE 1 0.0002
109 C-REACTIVE PROTEIN INCREASED 7 0.0002
110 PHARYNGOLARYNGEAL PAIN 1 0.0002
111 INTERVERTEBRAL DISC PROTRUSION 4 0.0002
112 ASTHENOPIA 1 0.0002
113 CHOKING SENSATION 1 0.0002
114 DRUG LEVEL INCREASED 3 0.0002
115 PERONEAL NERVE PALSY 1 0.0002
116 HYPERTONIA 1 0.0002
117 PERIPHERAL SENSORY NEUROPATHY 1 0.0002
118 SINUS HEADACHE 1 0.0002
119 GANGRENE 1 0.0002
120 CYST 2 0.0002
121 OLIGURIA 1 0.0002
122 BLOOD ALKALINE PHOSPHATASE INCREASED 4 0.0002
123 PRE-EXISTING CONDITION IMPROVED 1 0.0002
124 SCREAMING 1 0.0002
125 ENTERITIS 1 0.0002
126 PLATELET COUNT INCREASED 2 0.0002
127 DYSGRAPHIA 1 0.0002
128 WALKING AID USER 1 0.0002
129 PROSTATIC SPECIFIC ANTIGEN INCREASED 2 0.0001
130 DISSEMINATED INTRAVASCULAR COAGULATION 2 0.0001
131 PAPULE 1 0.0001
132 FAECES SOFT 1 0.0001
133 BONE PAIN 8 0.0001
134 PULMONARY MASS 2 0.0001
135 ECONOMIC PROBLEM 2 0.0001
136 RENAL IMPAIRMENT 11 0.0001
137 RENAL FAILURE CHRONIC 1 0.0001
138 TENDONITIS 2 0.0001
139 DRUG SCREEN POSITIVE 1 0.0001
140 FURUNCLE 1 0.0001
141 BLOOD ALBUMIN DECREASED 1 0.0001
142 RENAL CYST 1 0.0001
143 SCIATICA 2 0.0001
144 DECUBITUS ULCER 1 0.0001
145 UPPER-AIRWAY COUGH SYNDROME 1 0.0001
146 VITAMIN D DECREASED 1 0.0001
147 ERECTILE DYSFUNCTION 3 0.0001
148 SKIN HYPERPIGMENTATION 1 0.0001
149 GASTROINTESTINAL DISORDER 10 0.0001
150 LEUKOCYTOSIS 2 0.0001
151 LIP DRY 1 0.0001
152 END STAGE RENAL DISEASE 2 0.0001
153 RETINAL DETACHMENT 1 0.0001
154 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
155 HAEMOPTYSIS 3 0.0001
156 DEFORMITY 1 0.0001
157 PHOTOPHOBIA 2 0.0001
158 WHITE BLOOD CELL COUNT INCREASED 4 0.0001
159 SINUS BRADYCARDIA 1 0.0001
160 DYSSTASIA 3 0.0001
161 PARKINSONISM 1 0.0001
162 PHARYNGEAL SWELLING 1 0.0001
163 LIGAMENT SPRAIN 1 0.0001
164 EMPHYSEMA 1 0.0001
165 MOTOR DYSFUNCTION 1 0.0001
166 NEUTROPHIL COUNT INCREASED 1 0.0001
167 RIB FRACTURE 2 0.0001
168 TEMPERATURE INTOLERANCE 1 0.0001
169 POLLAKIURIA 4 0.0001
170 INCONTINENCE 1 0.0001
171 RENAL PAIN 1 0.0001
172 DECREASED ACTIVITY 1 0.0001
173 PHARYNGITIS STREPTOCOCCAL 1 0.0001
174 MICTURITION URGENCY 1 0.0001
175 MYOCARDITIS 1 0.0001
176 NEOPLASM 1 0.0001
177 SHOCK 2 0.0001
178 SPLENOMEGALY 1 0.0001
179 SEXUAL DYSFUNCTION 1 0.0001
180 NEUROLEPTIC MALIGNANT SYNDROME 1 0.0001
181 BLOOD IRON DECREASED 1 0.0001
182 ATAXIA 1 0.0001
183 WRIST FRACTURE 1 0.0001
184 HEPATITIS C 1 0.0001
185 NOCTURIA 1 0.0001
186 GENERALISED OEDEMA 1 0.0001
187 ANOREXIA 1 0.0001
188 PULMONARY CONGESTION 1 0.0001
189 QUALITY OF LIFE DECREASED 1 0.0001
190 OEDEMA 4 0.0001
191 LYMPHOPENIA 1 0.0001
192 PAIN IN JAW 2 0.0001
193 IMPAIRED QUALITY OF LIFE 1 0.0001
194 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
195 SKIN HAEMORRHAGE 1 0.0001
196 RENAL INJURY 2 0.0001
197 CATARACT 4 0.0001
198 CHRONIC KIDNEY DISEASE 5 0.0001
199 OEDEMA PERIPHERAL 8 0.0001
200 INSURANCE ISSUE 1 0.0001
201 ALANINE AMINOTRANSFERASE INCREASED 4 0.0001
202 PHARYNGEAL OEDEMA 1 0.0001
203 THYROID DISORDER 1 0.0001
204 MUSCULOSKELETAL CHEST PAIN 1 0.0001
205 ANKLE FRACTURE 1 0.0001
206 LUNG INFECTION 1 0.0001
207 COGNITIVE DISORDER 3 0.0001
208 SWOLLEN TONGUE 2 0.0001
209 PRODUCT USE COMPLAINT 1 0.0001
210 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
211 PRODUCTIVE COUGH 3 0.0001
212 CYSTITIS 2 0.0001
213 OBESITY 1 0.0001
214 IMPAIRED HEALING 2 0.0001
215 MULTIPLE FRACTURES 1 0.0001
216 TYPE 2 DIABETES MELLITUS 2 0.0001
217 FACE OEDEMA 1 0.0001
218 DISEASE PROGRESSION 7 0.0001
219 ACUTE KIDNEY INJURY 9 0.0001
220 SCAR 1 0.0001
221 HYPERKALAEMIA 2 0.0001
222 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
223 BRADYCARDIA 3 0.0001
224 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
225 RASH PRURITIC 3 0.0001
226 HEPATIC STEATOSIS 1 0.0001
227 NECK PAIN 3 0.0001
228 BACTERIAL INFECTION 1 0.0001
229 HEPATIC CIRRHOSIS 1 0.0001
230 FLATULENCE 3 0.0001
231 BLOOD URINE PRESENT 1 0.0001
232 DIABETES MELLITUS 4 0.0001
233 SLEEP APNOEA SYNDROME 1 0.0001
234 ACUTE RESPIRATORY FAILURE 1 0.0001
235 PRESCRIBED OVERDOSE 1 0.0001
236 KIDNEY INFECTION 1 0.0001
237 DISABILITY 1 0.0001
238 SINUS DISORDER 1 0.0001
239 BLOOD PRESSURE ABNORMAL 1 0.0001
240 UPPER LIMB FRACTURE 1 0.0001
241 PRODUCT ADMINISTRATION ERROR 1 0.0000
242 PERITONITIS 1 0.0000
243 HALLUCINATION, VISUAL 1 0.0000
244 EATING DISORDER 1 0.0000
245 IRRITABLE BOWEL SYNDROME 1 0.0000
246 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
247 AMNESIA 3 0.0000
248 PRODUCT DISPENSING ERROR 1 0.0000
249 MUSCULOSKELETAL STIFFNESS 4 0.0000
250 APPLICATION SITE PAIN 1 0.0000
251 ANGIOEDEMA 2 0.0000
252 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
253 COLITIS ULCERATIVE 2 0.0000
254 BACK PAIN 10 0.0000
255 BLOOD CHOLESTEROL INCREASED 2 0.0000
256 BURNING SENSATION 3 0.0000
257 LOCALISED INFECTION 1 0.0000
258 NEURALGIA 1 0.0000
259 ARTHRALGIA 17 0.0000
260 LUNG DISORDER 2 0.0000
261 LIVER INJURY 1 0.0000
262 ABASIA 1 0.0000
263 AGEUSIA 1 0.0000
264 HYPOPHAGIA 1 0.0000
265 HEPATITIS 1 0.0000
266 SINUSITIS 4 0.0000
267 DRUG RESISTANCE 1 0.0000
268 SKIN ULCER 1 0.0000
269 RASH GENERALISED 1 0.0000
270 PHARMACEUTICAL PRODUCT COMPLAINT 1 0.0000
271 DIPLOPIA 1 0.0000
272 RESPIRATORY TRACT INFECTION 1 0.0000
273 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
274 ARTHRITIS 3 0.0000
275 ANHEDONIA 1 0.0000
276 DRUG INTERACTION 6 0.0000
277 PNEUMONITIS 1 0.0000
278 MENTAL STATUS CHANGES 1 0.0000
279 URTICARIA 6 0.0000
280 BLISTER 2 0.0000
281 TARDIVE DYSKINESIA 1 0.0000
282 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
283 DEPRESSION 8 0.0000
284 HYPERSOMNIA 1 0.0000
285 BALANCE DISORDER 3 0.0000
286 ASCITES 1 0.0000
287 LABORATORY TEST ABNORMAL 1 0.0000
288 URINARY INCONTINENCE 1 0.0000
289 SWELLING 3 0.0000
290 HEAD INJURY 1 0.0000
291 NEUROPATHY PERIPHERAL 3 0.0000
292 METABOLIC ACIDOSIS 1 0.0000
293 HIP FRACTURE 1 0.0000
294 RHINORRHOEA 2 0.0000
295 PNEUMONIA 10 0.0000
296 EYE DISORDER 1 0.0000
297 RENAL FAILURE 4 0.0000
298 LIP SWELLING 1 0.0000
299 FUNGAL INFECTION 1 0.0000
300 SKIN DISORDER 1 0.0000
301 URINARY RETENTION 1 0.0000
302 GAIT INABILITY 1 0.0000
303 CHEST DISCOMFORT 3 0.0000
304 ERYTHEMA 6 0.0000
305 MULTIPLE SCLEROSIS RELAPSE 2 0.0000
306 NIGHTMARE 1 0.0000
307 RASH MACULAR 1 0.0000
308 HYPOXIA 1 0.0000
309 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
310 MOBILITY DECREASED 2 0.0000
311 DRUG EFFECT INCOMPLETE 1 0.0000
312 HYPERGLYCAEMIA 1 0.0000
313 UNDERDOSE 2 0.0000
314 ACCIDENTAL OVERDOSE 1 0.0000
315 DYSURIA 1 0.0000
316 DYSARTHRIA 1 0.0000
317 INTESTINAL OBSTRUCTION 1 0.0000
318 UNEVALUABLE EVENT 2 0.0000
319 INJECTION SITE SWELLING 2 0.0000
320 PERIPHERAL SWELLING 4 0.0000
321 ABNORMAL BEHAVIOUR 1 0.0000
322 JOINT SWELLING 3 0.0000
323 DIARRHOEA 16 0.0000
324 EXTRA DOSE ADMINISTERED 1 0.0000
325 DRY MOUTH 2 0.0000
326 DYSKINESIA 1 0.0000
327 BLINDNESS 1 0.0000
328 NEUTROPHIL COUNT DECREASED 1 0.0000
329 OSTEOPOROSIS 1 0.0000
330 PRODUCT USE IN UNAPPROVED INDICATION 6 0.0000
331 VISUAL IMPAIRMENT 3 0.0000
332 RHABDOMYOLYSIS 1 0.0000
333 MYALGIA 4 0.0000
334 PRURITUS 9 0.0000
335 SEPTIC SHOCK 1 0.0000
336 DEHYDRATION 3 0.0000
337 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
338 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 4 0.0000
339 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
340 SKIN IRRITATION 1 0.0000
341 SKIN DISCOLOURATION 1 0.0000
342 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
343 HYPERSENSITIVITY 4 0.0000
344 RENAL DISORDER 1 0.0000
345 VOMITING 10 0.0000
346 ARRHYTHMIA 1 0.0000
347 OCULAR HYPERAEMIA 1 0.0000
348 GAIT DISTURBANCE 4 0.0000
349 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
350 HEADACHE 13 0.0000
351 HYPOGLYCAEMIA 1 0.0000
352 ATRIAL FIBRILLATION 2 0.0000
353 PAIN IN EXTREMITY 6 0.0000
354 DYSPEPSIA 2 0.0000
355 HEART RATE INCREASED 2 0.0000
356 DRY EYE 1 0.0000
357 LEUKOPENIA 1 0.0000
358 AGGRESSION 1 0.0000
359 HYPOTENSION 4 0.0000
360 THERAPY CESSATION 1 0.0000
361 DYSPNOEA 11 0.0000
362 PANCREATITIS 1 0.0000
363 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
364 DISTURBANCE IN ATTENTION 1 0.0000
365 RASH 8 0.0000
366 CONSTIPATION 4 0.0000
367 TREATMENT NONCOMPLIANCE 1 0.0000
368 TREMOR 3 0.0000
369 HYPONATRAEMIA 1 0.0000
370 ANXIETY 5 0.0000
371 ABDOMINAL PAIN 4 0.0000
372 PALPITATIONS 2 0.0000
373 CHILLS 2 0.0000
374 SURGERY 1 0.0000
375 WHEEZING 1 0.0000
376 FATIGUE 13 0.0000
377 SUICIDE ATTEMPT 1 0.0000
378 STOMATITIS 1 0.0000
379 CONDITION AGGRAVATED 5 0.0000
380 PLEURAL EFFUSION 1 0.0000
381 VERTIGO 1 0.0000
382 DISCOMFORT 1 0.0000
383 DEEP VEIN THROMBOSIS 1 0.0000
384 SWELLING FACE 1 0.0000
385 BLOOD CREATININE INCREASED 1 0.0000
386 INFUSION RELATED REACTION 1 0.0000
387 FALL 5 0.0000
388 INSOMNIA 4 0.0000
389 INJECTION SITE PRURITUS 1 0.0000
390 NEUTROPENIA 2 0.0000
391 ABDOMINAL PAIN UPPER 3 0.0000
392 VISION BLURRED 2 0.0000
393 MEMORY IMPAIRMENT 2 0.0000
394 INJECTION SITE REACTION 1 0.0000
395 SLEEP DISORDER 1 0.0000
396 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
397 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
398 PRODUCT DOSE OMISSION ISSUE 4 0.0000
399 BRONCHITIS 1 0.0000
400 EPISTAXIS 1 0.0000
401 HYPOAESTHESIA 2 0.0000
402 ASTHENIA 5 0.0000
403 BLOOD PRESSURE INCREASED 2 0.0000
404 HOSPITALISATION 2 0.0000
405 NAUSEA 10 0.0000
406 OFF LABEL USE 11 0.0000
407 INJECTION SITE HAEMORRHAGE 1 0.0000
408 THROMBOSIS 1 0.0000
409 INFLUENZA LIKE ILLNESS 1 0.0000
410 DIZZINESS 6 0.0000
411 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
412 ABDOMINAL DISCOMFORT 2 0.0000
413 URINARY TRACT INFECTION 2 0.0000
414 PYREXIA 4 0.0000
415 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
416 DRUG WITHDRAWAL SYNDROME 1 0.0000
417 ADVERSE DRUG REACTION 1 0.0000
418 NASOPHARYNGITIS 2 0.0000
419 PRODUCT USE ISSUE 2 0.0000
420 BLOOD GLUCOSE INCREASED 2 0.0000
421 PAIN 6 0.0000
422 HAEMOGLOBIN DECREASED 1 0.0000
423 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
424 HAEMORRHAGE 1 0.0000
425 PLATELET COUNT DECREASED 1 0.0000
426 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
427 MALAISE 4 0.0000
428 INFLUENZA 1 0.0000
429 SEPSIS 1 0.0000
430 WEIGHT INCREASED 2 0.0000
431 MUSCULAR WEAKNESS 1 0.0000
432 SEIZURE 1 0.0000
433 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
434 DECREASED APPETITE 2 0.0000
435 EMOTIONAL DISTRESS 1 0.0000
436 INJECTION SITE ERYTHEMA 1 0.0000
437 HYPERHIDROSIS 1 0.0000
438 PRODUCT QUALITY ISSUE 1 0.0000
439 WEIGHT DECREASED 2 0.0000
440 COUGH 2 0.0000
441 DRUG INEFFECTIVE 8 0.0000
442 CEREBROVASCULAR ACCIDENT 1 0.0000
443 COVID-19 1 0.0000
444 NO ADVERSE EVENT 1 0.0000
445 MUSCLE SPASMS 1 0.0000
446 CHEST PAIN 1 0.0000
447 HYPERTENSION 1 0.0000
448 FEELING ABNORMAL 1 0.0000
449 DEATH 3 0.0000
450 INJECTION SITE PAIN 1 0.0000